Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 19 news stories from 15 outlets.

Prostate cancer affects about one in eight men each year, and is one of the most common types of cancer in men).

Prostate cancer affects about one in eight men each year, and is one of the most common types of cancer in men).

Prostate cancer affects about one in eight men each year, and is one of the most common types of cancer in men).

Prostate cancer affects about one in eight men each year, and is one of the most common types of cancer in men).

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 15 additional news stories.